Analysts at William Blair upped their FY2024 earnings estimates for Apellis Pharmaceuticals in a report issued on Tuesday, January 21st. William Blair analyst L. Hanbury-Brown now forecasts that the ...

This sale was conducted to cover tax withholding obligations related to the release of Restricted Stock Units on January 21, 2025. According to InvestingPro analysis, which offers comprehensive ...

Karen Lewis (JO:LEWJ), the Chief People Officer at Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.75 billion market cap ...

A Bradford Grammar School pupil is leading the ROW2025 challenge to raise funds for a kidney research charity in honour of his younger brother.

An England youth rower has launched a charity challenge at his school after his brother was diagnosed with an autoimmune ...

The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.

This Couple’s Transformation Is Giving Major Fitness Goals Real Life Weight Loss Story: Exercising Is Not Enough, Says Young Woman Who Lost 20 Kg With Balanced Diet And Consistent Workouts Prajakta ...

THE examination of the influence of drugs on amœbiasis has depended in large part on results obtained from experimentally infected laboratory animals. Conventional methods for the establishment ...